9.02  -0.14 (-1.53%)		05-29 13:27
Open: 9.22 High: 9.22 Volume: 64,121		Pre. Close: 9.16 Low: 8.9 Market Cap: 129(M)

Short term
Mid term
Targets	6-month :	11.15	1-year :	13.02
Resists	First :	9.55	Second :	11.15
Pivot price	8.76
Supports	First :	8.64	Second :	8.09
MAs	MA(5) :	9.12	MA(20) :	8.76
	MA(100) :	8.98	MA(250) :	9.53
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	72.4	D(3) :	81.6
RSI	RSI(14): 54.3
52-week	High :	13.46	Low :	7.5

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ JYNT ] has closed below upper band by 32.9%. Bollinger Bands are 16% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	9.5 - 9.55	9.55 - 9.58
Low:	9.04 - 9.1	9.1 - 9.14
Close:	9.07 - 9.16	9.16 - 9.23

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Tue, 26 May 2026
The Joint: Can Refranchising Unlock A Better Business? (NASDAQ:JYNT) - Seeking Alpha

Fri, 22 May 2026
Joint Corp (JYNT) director granted 5,714 restricted shares - Stock Titan

Fri, 22 May 2026
Joint Corp (JYNT) grants 5,714 restricted shares to director DaVella - Stock Titan

Fri, 22 May 2026
JOINT Corp (JYNT) director Matthew Rubel receives 5,714 restricted stock grant - Stock Titan

Thu, 21 May 2026
Shareholders at The Joint Corp. (NASDAQ: JYNT) approve board slate, pay and auditor - Stock Titan

Thu, 21 May 2026
The Joint Corp. Announces Milind Pant Elected as Director - GlobeNewswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Care Facilities
Shares Out	14 (M)
Shares Float	7 (M)
Held by Insiders	15.9 (%)
Held by Institutions	73.6 (%)
Shares Short	819 (K)
Shares Short P.Month	885 (K)

EPS	0.09
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.05
Profit Margin	5.7 %
Operating Margin	6 %
Return on Assets (ttm)	0.6 %
Return on Equity (ttm)	6.9 %
Qtrly Rev. Growth	13.3 %
Gross Profit (p.s.)	3.2
Sales Per Share	3.97
EBITDA (p.s.)	0.16
Qtrly Earnings Growth	43.7 %
Operating Cash Flow	4 (M)
Levered Free Cash Flow	9 (M)

PE Ratio	99.83
PEG Ratio	8.8
Price to Book value	8.47
Price to Sales	2.26
Price to Cash Flow	31.55

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.